News
11-16-2011, 10:01 PM
BioSante Pharmaceuticals, Inc., today announced additional results from its principal LibiGel (testosterone gel) pharmacokinetic (pK) study. Top line data from this study were announced on September 12, 2011.
More... (http://www.news-medical.net/news/20111116/Additional-results-from-BioSantes-LibiGel-pK-study-on-HSDD.aspx)
More... (http://www.news-medical.net/news/20111116/Additional-results-from-BioSantes-LibiGel-pK-study-on-HSDD.aspx)